Twist Bioscience (TWST) Change in Receivables (2017 - 2026)

Twist Bioscience (TWST) has reported Change in Receivables for 10 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Receivables rose 1347.13% year-over-year to $1.1 million in Q2 2026; TTM through Jun 2026 was $15.7 million, a 13.35% decrease from a year earlier, with the FY2025 full-year figure at $22.4 million, up 365.06% from the prior year.
• Change in Receivables was $1.1 million for Q2 2026 at Twist Bioscience, down from $14.2 million in the prior quarter.
• Over five years, Change in Receivables peaked at $14.2 million in Q1 2026 and troughed at -$8.1 million in Q4 2023.
• A 5-year average of $1.9 million and a median of $1.8 million in 2022 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables tumbled 328.28% in 2022 and soared 1531.96% in 2025, its largest moves.
• Over 5 years, Change in Receivables stood at $4.1 million in 2022, then plunged by 296.63% to -$8.1 million in 2023, then soared by 156.3% to $4.5 million in 2024, then slumped by 250.45% to -$6.8 million in 2025, then soared by 115.9% to $1.1 million in 2026.
• The last three Change in Receivables figures came in at $1.1 million (Q2 2026), $14.2 million (Q1 2026), and -$6.8 million (Q4 2025), per Business Quant data.